LSD2 is an Epigenetic Player in Multiple Types of Cancer and Beyond

• DOI: 10.20944/preprints202404.0749.v1
• Publication Date: 2024-04-18T10:55:13Z
• Authors: Hyun-Min Kim; Zifei Liu
• Keywords: Histone Demethylases; 0301 basic medicine; Jumonji Domain-Containing Histone Demethylases; DNA Repair; F-Box Proteins; LSD1; Review; LSD2; DNA Methylation; Microbiology; QR1-502; Epigenesis, Genetic; Histones; Gene Expression Regulation, Neoplastic; 03 medical and health sciences; AOF1; KDM1B; KDM1A; histone demethylase; Neoplasms; Humans

Histone demethylases, enzymes responsible for removing methyl groups from histone proteins, have emerged as critical players in regulating gene expression and chromatin dynamics, thereby influencing various cellular processes. LSD2 and LSD1 have attracted considerable interest among these demethylases because of their associations with cancer. However, while LSD1 has received significant attention, LSD2 has not been recognized to the same extent. In this study, we conduct a comprehensive comparison between LSD2 and LSD1, with a focus on exploring LSD2's implications. While both share structural similarities, LSD2 possesses unique features. Functionally, LSD2 shows diverse roles, particularly in cancer, with tissue-dependent roles. Additionally, LSD2 extends beyond histone demethylation, impacting DNA methylation and DNA damage repair pathways. This study underscores the distinct roles of LSD2, providing insights into their contributions to cancer and other cellular processes.